This study aimed to determine whether pharmacy customers are deterred from using a pharmacy that offers services to drug misusers. If patients are deterred, what are their specific concerns? The study was qualitative and three different groups were interviewed about their views on pharmacies providing services to drug misusers (i) pharmacy customers, (ii) local community councils and (iii) local drug forums. This paper focuses on pharmacy customer interview results. Interviews were conducted in 10 pharmacies, five in Aberdeen and five in Glasgow, both areas of high drug misuse. The pharmacy customers were attending pharmacies with high, medium and low involvement with drug misusers and were located in city centre, suburban and rural locations. Pharmacy customers were generally supportive of pharmacies offering services to drug misusers. However, their support was often qualified by a wish to see a private area provided for methadone consumption. Pharmacy customers were more knowledgeable of the rationale for and supportive of needle exchange services compared to methadone maintenance and supervised consumption. The results of the study demonstrate that the majority of pharmacy customers are supportive of drug misuse services, provided there is adequate privacy in the pharmacy. These results should be used to encourage more pharmacists to provide drug misuse services.
[1]
C. Bond,et al.
Community pharmacy services for drug misusers in Scotland: what difference does 5 years make?
,
2002,
Addiction.
[2]
J. Marsden,et al.
Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study.
,
2001,
Drug and alcohol dependence.
[3]
S. Hutchinson,et al.
One-year follow-up of opiate injectors treated with oral methadone in a GP-centred programme.
,
2000,
Addiction.
[4]
C. Bond,et al.
Motivations for and barriers to community pharmacy services for drug misusers
,
1999
.
[5]
C. Matheson.
Views of illicit drug users on their treatment and behaviour in Scottish community pharmacies: implications for the harm-reduction strategy
,
1998
.
[6]
C. Matheson.
PRIVACY AND STIGMA IN THE PHARMACY : ILLICIT DRUG USERS' PERSPECTIVES AND IMPLICATIONS FOR PHARMACY PRACTICE
,
1998
.
[7]
E. Teijlingen,et al.
PHARMACISTS' APPROACH TO HARM MINIMISATION INITIATIVES ASSOCIATED WITH PROBLEM DRUG USE : THE LOTHIAN SURVEY
,
1998
.